0001209191-22-006022.txt : 20220201 0001209191-22-006022.hdr.sgml : 20220201 20220201181426 ACCESSION NUMBER: 0001209191-22-006022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220130 FILED AS OF DATE: 20220201 DATE AS OF CHANGE: 20220201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gerngross Tillman U. CENTRAL INDEX KEY: 0001722061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40703 FILM NUMBER: 22580560 MAIL ADDRESS: STREET 1: C/O ARSANIS, INC. STREET 2: 890 WINTER STREET, SUITE 230 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adagio Therapeutics, Inc. CENTRAL INDEX KEY: 0001832038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851403134 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 819-0080 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-30 0 0001832038 Adagio Therapeutics, Inc. ADGI 0001722061 Gerngross Tillman U. C/O ADAGIO THERAPEUTICS, INC. 1601 TRAPELO ROAD, SUITE 178 WALTHAM MA 02451 1 1 1 0 Chief Executive Officer Stock Option (Right to Buy) 6.78 2022-01-30 4 A 0 175000 0.00 A 2032-01-29 Common Stock 175000 175000 D This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date. /s/ Jane Pritchett Henderson, Attorney-in-Fact 2022-02-01